Aurobac Therapeutics

Aurobac Therapeutics is a biotech company in France, founded in 2022. It has raised $43.2M across 1 round, most recently a $43.2M Corporate Round in July 2022.

Founded
2022
Business Model
B2B
Total Funding
$43.2M
Last Round
$43.2M Corporate RoundJul 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.

About

AUROBAC THERAPEUTICS is a biopharmaceutical company founded in 2022 by Boehringer Ingelheim, Evotec and bioMerieux, developing patient- and pathogen-targeted therapies to combat serious bacterial infections and Antimicrobial Resistance (AMR) in acute hospital settings, including hospital-acquired pneumonia and sepsis. Its diagnostic-driven R&D strategy spans research through commercialization, with entities in France, the UK, and the US.

Summary

It has raised $43.2M in total across 1 round, most recently a $43.2M Corporate Round in Jul 2022. Investors include Boehringer Ingelheim Venture Fund, Evotec and bioMerieux.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Corporate RoundCorporate RoundJul 2022
$43.2M

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aurobac Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/aurobac-therapeutics"><img src="https://indexed.vc/api/badge/company/aurobac-therapeutics" alt="Aurobac Therapeutics on Indexed.vc" width="260" height="76" /></a>